Erika Bujáki

1.1k total citations
13 papers, 418 citations indexed

About

Erika Bujáki is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Erika Bujáki has authored 13 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in Erika Bujáki's work include Viral Infections and Immunology Research (10 papers), Viral gastroenteritis research and epidemiology (8 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Erika Bujáki is often cited by papers focused on Viral Infections and Immunology Research (10 papers), Viral gastroenteritis research and epidemiology (8 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Erika Bujáki collaborates with scholars based in United Kingdom, United States and Uganda. Erika Bujáki's co-authors include Javier Martín, Manasi Majumdar, Thomas Wilton, Dimitra Klapsa, Ryan Mate, Martin Fritzsche, Maria Zambon, Raul Andino, Amy J. Weiner and Andrew Macadam and has published in prestigious journals such as Cell Host & Microbe, Viruses and Microbiology Spectrum.

In The Last Decade

Erika Bujáki

10 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Bujáki United Kingdom 7 330 185 90 76 68 13 418
Thomas Wilton United Kingdom 8 320 1.0× 180 1.0× 82 0.9× 79 1.0× 68 1.0× 14 412
Maria do Carmo Debur Brazil 11 162 0.5× 46 0.2× 72 0.8× 162 2.1× 67 1.0× 17 309
María Piñana Spain 13 212 0.6× 62 0.3× 69 0.8× 202 2.7× 17 0.3× 27 353
Thomas Mehoke United States 9 163 0.5× 26 0.1× 76 0.8× 58 0.8× 69 1.0× 18 332
Guohong Huang China 11 182 0.6× 77 0.4× 91 1.0× 198 2.6× 12 0.2× 24 369
Morgan R. Herod United Kingdom 11 102 0.3× 128 0.7× 66 0.7× 45 0.6× 20 0.3× 26 270
Shuizhen He China 12 256 0.8× 252 1.4× 80 0.9× 126 1.7× 52 0.8× 29 435
Lee Sherry United Kingdom 8 132 0.4× 124 0.7× 82 0.9× 61 0.8× 6 0.1× 18 268
Tatiana P. Eremeeva Russia 8 236 0.7× 204 1.1× 59 0.7× 98 1.3× 8 0.1× 11 321
Pirom Noisumdaeng Thailand 10 138 0.4× 90 0.5× 44 0.5× 204 2.7× 11 0.2× 26 324

Countries citing papers authored by Erika Bujáki

Since Specialization
Citations

This map shows the geographic impact of Erika Bujáki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Bujáki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Bujáki more than expected).

Fields of papers citing papers by Erika Bujáki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Bujáki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Bujáki. The network helps show where Erika Bujáki may publish in the future.

Co-authorship network of co-authors of Erika Bujáki

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Bujáki. A scholar is included among the top collaborators of Erika Bujáki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Bujáki. Erika Bujáki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Bujáki, Erika, Vincent Caval, Marie‐Line Joffret, et al.. (2024). Opening a 60-year time capsule: sequences of historical poliovirus cold variants shed a new light on a contemporary strain. Virus Evolution. 10(1). veae063–veae063.
3.
O’Toole, Áine, Rachel Colquhoun, Daniel Maloney, et al.. (2024). Automated detection and classification of polioviruses from nanopore sequencing reads using piranha. Virus Evolution. 10(1). veae023–veae023. 2 indexed citations
4.
Bujáki, Erika, Alex Shaw, Adnan Khurshid, et al.. (2023). Comparison of Eleven RNA Extraction Methods for Poliovirus Direct Molecular Detection in Stool Samples. Microbiology Spectrum. 11(2). e0425222–e0425222. 6 indexed citations
5.
Wilton, Thomas, Dimitra Klapsa, Erika Bujáki, et al.. (2022). Detection of Enterovirus D68 in Wastewater Samples from the UK between July and November 2021. Viruses. 14(1). 143–143. 23 indexed citations
6.
Wilton, Thomas, Erika Bujáki, Dimitra Klapsa, et al.. (2021). Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021. mSystems. 6(3). e0035321–e0035321. 46 indexed citations
7.
Majumdar, Manasi, Dimitra Klapsa, Thomas Wilton, et al.. (2021). High Diversity of Human Non-Polio Enterovirus Serotypes Identified in Contaminated Water in Nigeria. Viruses. 13(2). 249–249. 17 indexed citations
8.
Bujáki, Erika, et al.. (2020). Distribution of enterovirus genotypes detected in clinical samples in Hungary, 2010–2018. Acta Microbiologica et Immunologica Hungarica. 67(4). 201–208. 6 indexed citations
9.
Martín, Javier, Dimitra Klapsa, Thomas Wilton, et al.. (2020). Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic. Viruses. 12(10). 1144–1144. 109 indexed citations
10.
Yeh, Ming Te, Erika Bujáki, Patrick Dolan, et al.. (2020). Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence. Cell Host & Microbe. 27(5). 736–751.e8. 136 indexed citations
11.
Konopka‐Anstadt, Jennifer L., Raymond P. Campagnoli, Annelet Vincent, et al.. (2020). Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization. npj Vaccines. 5(1). 26–26. 66 indexed citations
12.
Yeh, Ming Te, Erika Bujáki, Matthew D. Smith, et al.. (2019). A New Live-Attenuated Poliovirus Vaccine Constructed by Rational Design Improves Safety by Preventing Reversion to Virulence. SSRN Electronic Journal.
13.
Cooper, Jillian K., et al.. (2013). Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt–Jakob disease. Vox Sanguinis. 105(3). 196–204. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Wilton Breakdown of academic impact, for papers by Maria do Carmo Debur Breakdown of academic impact, for papers by María Piñana Breakdown of academic impact, for papers by Thomas Mehoke Breakdown of academic impact, for papers by Guohong Huang Breakdown of academic impact, for papers by Morgan R. Herod Breakdown of academic impact, for papers by Shuizhen He Breakdown of academic impact, for papers by Lee Sherry Breakdown of academic impact, for papers by Tatiana P. Eremeeva Breakdown of academic impact, for papers by Pirom Noisumdaeng
Rankless by CCL
2026